South Korea Metagenomics Market Size & Outlook, 2024-2030

The metagenomics market in South Korea is expected to reach a projected revenue of US$ 65.2 million by 2030. A compound annual growth rate of 13.8% is expected of South Korea metagenomics market from 2024 to 2030.
Revenue, 2023 (US$M)
$27.1
Forecast, 2030 (US$M)
$65.2
CAGR, 2024 - 2030
13.8%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea metagenomics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea metagenomics market highlights

  • The South Korea metagenomics market generated a revenue of USD 27.0 million in 2023 and is expected to reach USD 65.2 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 13.4% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.


Metagenomics market data book summary

Market revenue in 2023USD 27.0 million
Market revenue in 2030USD 65.2 million
Growth rate13.4% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentSequencing & Data Analytics Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Sequencing & Data Analytics Services, Software
Key market players worldwideBio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.3% of the global metagenomics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China metagenomics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 244.2 million by 2030.

Kits & reagents was the largest segment with a revenue share of 61.48% in 2023. Horizon Databook has segmented the South Korea metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.


South Korea exhibits strong potential for R&D capabilities in pharmaceutical and biopharmaceutical sectors, which is expected to boost the demand for NGS products in research. Cancer research has become a national priority for the Korean government. It supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create major demand for NGS products in the coming years.

Furthermore, increasing R&D investments by key pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth. For instance, in June 2019, AstraZeneca announced its plans to spend USD 630.0 million on R&D in South Korea over the next 5 years.

Similarly, in June 2022, Theragen Bio was selected for a state project to develop advanced chips for genomic analysis, which would be useful in identifying the genetic cause of chronic diseases in the Korean population.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Metagenomics Market Companies

Name Profile # Employees HQ Website
Oxford Nanopore Technologies PLC View profile 1133 Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQ https://www.nanoporetech.com
Promega View profile 5001-10000 Madison, Wisconsin, United States, North America http://www.promega.com/es
Novogene View profile 501-1000 Beijing, Beijing, China, Asia https://en.novogene.com/
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Takara Bio Inc View profile 1793 Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 http://www.takara-bio.co.jp
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

South Korea metagenomics market size, by product, 2018-2030 (US$M)

South Korea Metagenomics Market Outlook Share, 2023 & 2030 (US$M)

South Korea metagenomics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online